California Stem Cell Audit: Praise for Mills but More Work Needed on IP, Conflicts of Interest
The California stem cell agency this week received good marks for changes made by its new president, but it is also being told that it needs to improve how it tracks potential royalties and how it prevents grant reviewer conflicts of interest.
A "performance audit" by Moss-Adams, a Seattle business consulting firm, made 12 recommendations for the $3 bill…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.